Hisashi Masuyama
Dept. of Obstetrics and Gynecology
Okayama Univ. Graduate School of Medicine
Dentistry and Pharmaceutical Sciences
2-5-1
Japan
Name/email consistency: high
- Treatment with constitutive androstane receptor ligand during pregnancy prevents insulin resistance in offspring from high-fat diet-induced obese pregnant mice. Masuyama, H., Hiramatsu, Y. Am. J. Physiol. Endocrinol. Metab. (2012)
- Effects of a High-Fat Diet Exposure in Utero on the Metabolic Syndrome-Like Phenomenon in Mouse Offspring through Epigenetic Changes in Adipocytokine Gene Expression. Masuyama, H., Hiramatsu, Y. Endocrinology (2012)
- Retinol-binding protein 4 and insulin resistance in preeclampsia. Masuyama, H., Inoue, S., Hiramatsu, Y. Endocr. J. (2011)
- Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. Masuyama, H., Segawa, T., Sumida, Y., Masumoto, A., Inoue, S., Akahori, Y., Hiramatsu, Y. BJOG (2010)
- Effect of oncostatin M on uridine diphosphate-5'-glucuronosyltransferase 1A1 through cross talk with constitutive androstane receptor. Masuyama, H., Nakatsukasa, H., Hiramatsu, Y. Mol. Endocrinol. (2010)
- Pregnancy after living-related liver transplantation associated with severe preeclampsia and a review of the literature. Masuyama, H., Matsuda, M., Shimizu, K., Segawa, T., Hiramatsu, Y. Arch. Gynecol. Obstet. (2010)
- Hyperreactio luteinalis with both markedly elevated human chorionic gonadotropin levels and an imbalance of angiogenic factors subsequently developed severe early-onset preeclampsia. Masuyama, H., Tateishi, Y., Matsuda, M., Hiramatrsu, Y. Fertil. Steril. (2009)
- Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. Masuyama, H., Nakatsukasa, H., Takamoto, N., Hiramatsu, Y. J. Clin. Endocrinol. Metab. (2007)
- Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Masuyama, H., Nakatsukasa, H., Takamoto, N., Hiramatsu, Y. Mol. Pharmacol. (2007)
- Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Masuyama, H., Suwaki, N., Nakatsukasa, H., Masumoto, A., Tateishi, Y., Hiramatrsu, Y. Am. J. Obstet. Gynecol. (2006)
- The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Masuyama, H., Suwaki, N., Tateishi, Y., Nakatsukasa, H., Segawa, T., Hiramatsu, Y. Mol. Endocrinol. (2005)
- Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors. Masuyama, H., Hiramatsu, Y. J. Biol. Chem. (2004)
- Expression and potential roles of pregnane X receptor in endometrial cancer. Masuyama, H., Hiramatsu, Y., Kodama, J., Kudo, T. J. Clin. Endocrinol. Metab. (2003)
- Ligands have various potential effects on the degradation of pregnane X receptor by proteasome. Masuyama, H., Inoshita, H., Hiramatsu, Y., Kudo, T. Endocrinology (2002)
- The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Masuyama, H., Hiramatsu, Y., Mizutani, Y., Inoshita, H., Kudo, T. Mol. Cell. Endocrinol. (2001)
- Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription. Masuyama, H., Hiramatsu, Y., Kunitomi, M., Kudo, T., MacDonald, P.N. Mol. Endocrinol. (2000)
